Buy Biohaven Pharmaceutical Hld Stock | BHVN Stock Price & Latest News | Public.com

Biohaven Pharmaceutical Hld

$0.00 (0.00%)Today

About BHVN

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidat...Read more

Community

People who own or watch this stock

News

News image
Biohaven Presents NURTEC™ (rimegepant) Clinical and Pharmacoeconomic Data at the American Headache Society (AHS) Virtual Annual Scientific Meeting
0
0
News image
Biohaven Showcases Clinical and Pharmacoeconomic Data for NURTEC™ ODT (rimegepant) with 25 Presentations on the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform
0
0
Load more

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.2

Price Targets

What analysts think this stock will be worth

$74.07
current
$70.20
average

Events

List of events that could affect this stock.

07May

Earnings data Q1 2020

06Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-1.02
-2.05
-3.07
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$2.25

Actual EPS
Q3 2020

Stats

Market Cap$4,33B
Volume13,78k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$78.75
1 Year Low$26.56
Open$75.53
High$75.83
Low$73.51

Buy any stock with any amount of money.

Download the App
Download the app